In 2018, Duke was part of the initial rollout of the Accrual to Clinical Trials (ACT) Network, a consortium of leading academic medical research centers nationwide sharing de-identified patient population counts, making it easier to determine and demonstrate feasibility of clinical trials and identify potential collaborators for multi-site studies.
At the time, the network had 20 members, all drawn from the nationwide CTSA consortium. Now the ACT Network has expanded to include 32 sites, with an additional 16 in the staging process. The patient population has grown to an estimated 100 million.
The network utilizes a unique cohort exploration tool (i2b2) that allows researchers to explore patient populations in depth, find cohorts that fit their study criteria, and get counts in real-time, all directly from their desktop.
Here is the complete list of ACT Network sites to date:
Emory Univ./Morehouse Univ.
Johns Hopkins University
Medical University of South Carolina
New York University
Oregon Health & Science University
University of Alabama at Birmingham
U. of Arkansas for Medical Sciences
University of California, Davis
University of California, Irvine
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
Univ of Cincinnati/Cincinnati Children’s
Univ of Colo/Children’s Hosp. Colorado
University of Florida
University of Kentucky
University of Minnesota
University of Pittsburgh
UT Health San Antonio
Vanderbilt University Medical Center
Washington University in St. Louis
Staging for ACT:
Medical College of Wisconsin
Ohio State University
University at Buffalo
University of Illinois-Chicago
University of Kansas
University of Massachusetts
University of Miami
University of New Mexico
University of Southern California
University of Utah
University of Washington
University of Wisconsin-Madison
Virginia Commonwealth Univ.
Weill Cornell Medicine